Alberta Purchasing #2026RSS0007

Direct Award for CEDIA and DRI Reagents and Controls for Toxicology Testing

This procurement involves a direct award by the University of Calgary's Alberta Centre for Toxicology (ACFT) for specialized laboratory reagents and consumables: - Government Buyer: - University of Calgary, Alberta Centre for Toxicology (ACFT) - Supports Alberta Health Services Opioid Dependency Program (ODP) - OEMs and Vendors: - Diagnostix Ltd (a Thermo Fisher Scientific company) is the sole vendor - Thermo Fisher Scientific is the OEM for CEDIA™ and DRI™ products - Products/Services Requested: - CEDIA™ and DRI™ reagents, calibrators, and controls - Used for urine drug testing - Compatible with DxC 500 AU and Olympus AU480 laboratory instruments - No specific part numbers or quantities provided - Unique/Notable Requirements: - Direct award to ensure standardization and compatibility with existing testing systems - Diagnostix Ltd identified as the only supplier able to meet operational and research needs - Procurement avoids additional validation, downtime, and costs associated with switching suppliers - Products classified under laboratory and clinical diagnostic analyzer reagents, manual test kits, quality controls, calibrators, and clinical chemistry testing systems

Description

The University of Calgary requires the purchase of CEDIA and DRI reagents, calibrators, and controls from Diagnostix Ltd, a Thermo Fisher Scientific company, to support urine drug testing for the Alberta Health Services Opioid Dependency Program. The procurement ensures standardization and consistency of testing across the AHS consortium by continuing the use of specific reagents compatible with current instruments. This direct award avoids significant validation, instrument downtime, additional costs, and minimizes testing errors. Diagnostix's reagents and consumables are understood to be the only products meeting the research and operational requirements.

View original listing